# EDGAR Filing Document

**Accession Number:** 0000874710
**File Stem:** 0001104659-23-003027
**Filing Date:** 2023-1
**Character Count:** 4770
**Document Hash:** 2524c16881ad7f4099f888f67f4dc275
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-003027.hdr.sgml**: 20230111

**ACCESSION NUMBER**: 0001104659-23-003027

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230109

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20230111

**DATE AS OF CHANGE**: 20230111

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ALLIED HEALTHCARE PRODUCTS INC
- **CENTRAL INDEX KEY:** 0000874710
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **IRS NUMBER:** 231370721
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-19266
- **FILM NUMBER:** 23523462

**BUSINESS ADDRESS:**
- **STREET 1:** 1720 SUBLETTE AVE
- **CITY:** ST LOUIS
- **STATE:** MO
- **ZIP:** 63110
- **BUSINESS PHONE:** 3147712400

**MAIL ADDRESS:**
- **STREET 1:** 1720 SUBLETTE AVENUE
- **CITY:** ST LOUIS
- **STATE:** MO
- **ZIP:** 63110

?xml version="1.0" encoding="utf-8"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549** 

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported)

January 9, 2023

**ALLIED HEALTHCARE PRODUCTS, INC.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **0-19266** | **25-1370721** |
| (State or Other Jurisdiction <br> of Incorporation) | (Commission <br> File Number) | (IRS Employer <br> Identification No.) |

---

---

| | |
|:---|:---|
| **1720 Sublette Avenue, St. Louis, Missouri**<br> (Address of principal executive offices) | **63110**<br> (Zip Code) |

---

---

| |
|:---|
| Registrant's telephone number, including area code |
| **(314) 771-2400** |
| Not applicable |
| **(Former name or former address, if changed since last report)** |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

◻ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging Growth Company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Title of Each Class | &nbsp;&nbsp;Trading Symbol | &nbsp;&nbsp;Name of Each Exchange on Which<br> Registered |
| &nbsp;&nbsp;Common Stock, $.01 | &nbsp;&nbsp;AHPI | &nbsp;&nbsp;The NASDAQ Stock Market, LLC |

---

**ITEM 8.01. Other Events.**

As previously reported, on November 10, 2022, Allied Healthcare Products, Inc. (the "Company") convened its 2022 Annual Meeting of Stockholders (the "Annual Meeting"). At that time, there were not present or represented by proxy a sufficient number of shares of the Company's common stock in order to constitute the required quorum. As a result, the Company adjourned the Annual Meeting until December 9, 2022 at 9:00 a.m. Central Time*.* At that time, there were again not present or represented by proxy a sufficient number of shares of the Company's common stock in order to constitute the required quorum. As a result, the Company again adjourned the Annual Meeting until January 9, 2023 at 9:00 a.m. Central Time*.* As of such time, the Company still has not received proxies representing a sufficient number of shares of the Company's common stock to constitute a quorum. As a result, the Company again adjourned the Annual Meeting until February 9, 2023 at 9:00 a.m. Central Time*.*

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | ALLIED HEALTHCARE PRODUCTS, INC. |
|  | By: |
| Date: January 11, 2023 | /s/ Daniel C. Dunn |
|  | Daniel C. Dunn |
|  | Chief Financial Officer |

---